
20:53 ET QURE Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

I'm PortAI, I can summarize articles.
Kessler Topaz Meltzer & Check, LLP is investigating potential federal securities law violations by uniQure N.V. (NASDAQ: QURE) after the FDA found insufficient evidence for its AMT-130 gene therapy's Biologics License Application. Following this news, uniQure's stock price fell over 50%. Investors with significant losses are encouraged to contact the firm for more information.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

